HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Ueoka Selected Research

Drug Therapy (Chemotherapy)

12/2004Addition of platinum compounds to a new agent in patients with advanced non-small-cell lung cancer: a literature based meta-analysis of randomised trials.
7/2001Generation of cytotoxic T lymphocytes against autologous lung cancer cells resistant to apoptosis.
12/2000Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicate poor prognosis.
11/2000Intramedullary spinal cord recurrence after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation for limited-disease small cell lung cancer.
1/2000Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Ueoka Research Topics

Disease

11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2005 - 01/2000
6Lung Neoplasms (Lung Cancer)
11/2005 - 01/2000
6Neoplasms (Cancer)
10/2001 - 03/2000
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2001 - 03/2000
2Neoplasm Metastasis (Metastasis)
12/2000 - 11/2000
1Pleural Effusion (Pleural Effusions)
10/2017
1Disease Progression
11/2005
1Radiation Pneumonitis
02/2002
1Adenocarcinoma
07/2001
1Lung Diseases (Lung Disease)
04/2001
1Subdural Hematoma (Subdural Hemorrhage)
03/2001
1Chronic Subdural Hematoma
03/2001
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
03/2001
1Diarrhea
12/2000
1Leukopenia
12/2000
1Nervous System Diseases (Neurological Disorders)
11/2000
1Weight Loss (Weight Reduction)
05/2000
1Carcinogenesis
05/2000
1Neutropenia
01/2000

Drug/Important Bio-Agent (IBA)

7Cisplatin (Platino)FDA LinkGeneric
03/2004 - 01/2000
3Irinotecan (Camptosar)FDA LinkGeneric
02/2002 - 12/2000
2PlatinumIBA
12/2004 - 01/2000
2Docetaxel (Taxotere)FDA Link
03/2004 - 09/2003
2Phosphopyruvate Hydratase (Enolase)IBA
04/2001 - 12/2000
1Immunoglobulins (Immunoglobulin)IBA
10/2017
1Immunoglobulin G (IgG)IBA
10/2017
1Gefitinib (Iressa)FDA Link
11/2005
1Platinum Compounds (Compounds, Platinum)IBA
12/2004
1big gastrinIBA
04/2001
1pro-gastrin-releasing peptide (31-98)IBA
04/2001
1Peptides (Polypeptides)IBA
04/2001
1Inosine Triphosphate (ITP)IBA
03/2001
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
03/2001
1kamikihi-to (KKT)IBA
03/2001
1Prednisolone (Predate)FDA LinkGeneric
03/2001
1Serum AlbuminIBA
12/2000
1Gadolinium DTPA (Magnevist)FDA Link
11/2000
1Proteins (Proteins, Gene)FDA Link
07/2000
1Monoclonal AntibodiesIBA
07/2000
1CarcinogensIBA
05/2000
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
05/2000
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2000
1Keratin-19 (Keratin 19)IBA
03/2000
1Messenger RNA (mRNA)IBA
03/2000
1Bombesin Receptors (Bombesin Receptor)IBA
03/2000
1nedaplatinIBA
01/2000
1Fluorouracil (Carac)FDA LinkGeneric
01/2000
1Vindesine (Vindesin)IBA
01/2000

Therapy/Procedure

5Drug Therapy (Chemotherapy)
12/2004 - 01/2000
4Radiotherapy
09/2003 - 11/2000
3Chemoradiotherapy
03/2004 - 01/2000
1Surgical Instruments (Clip)
11/2003
1Induction Chemotherapy
02/2002
1Therapeutics
07/2001
1Transplantation
11/2000